BSE stock falls 3%: Bernstein initiates with ‘underperform’ as derivatives growth normalises; check…

Fresh updates from the financial markets indicate that BSE Ltd shares declined more than 3 percent in the early trading on Wednesday after Bernstein initiated coverage on the stock with an ‘underperform’ rating. Market watchers stated that the stock exchange is entering a normalisation phase after firm expansion fuelled by rising retail participation in equity derivatives.
Bernstein set a target price of Rs 2,820 per share on BSE stock, implying downside of around 17 percent from Tuesday’s closing price. BSE shares were trading at Rs 3,285, down 3.2 percent from the previous close. Despite the recent softness, the stock stays up 29.2 percent so far in 2026, with the exchange commanding a market capitalisation of more than Rs 1.38 lakh crore.
The brokerage stated retail participation has fuelled firm earnings expansion and valuation upside for Indian exchanges in recent years. That stated, the equity derivatives-led retail wave is now showing signs of moderation, potentially weighing on the expansion trajectory of exchanges heavily exposed to the segment.
Share Markets Live Updates | Sensex, Nifty, GIFT Nifty Today
For BSE, Bernstein anticipates market-share upside to peak in FY27, with expansion subsequently normalising. The view suggests that the sharp expansion enjoyed by the exchange as it built its presence in equity derivatives may become harder to sustain from here.
The wary Bernstein view comes amid broader concerns over trading volumes at BSE. The exchange's management has acknowledged that the recently introduced Closing Auction Session (CAS) has resulted in softer index options volumes, with limited liquidity in the auction session affecting participation.
The CAS framework, introduced by SEBI on August 3 to determine closing prices in the cash market, has additionally faced scrutiny over divergent index closing marks across exchanges, volatility in options pricing and concerns around expiry-day trading. SEBI stated last week that it would review the methodology for determining derivatives settlement prices after receiving feedback on the new mechanism.
Separately, the gain in securities transaction tax (STT) and its potential impact on trading activity have further noted to concerns around the earnings outlook for exchanges. Other research firms, including Nuvama and Jefferies, have recently turned more wary on BSE. PL Capital trimmed its target price to Rs 4,025 from Rs 4,850, although it retained a ‘buy’ rating.
In the meantime, Bernstein is more constructive on Multi Commodity Exchange of India (MCX), initiating coverage with an ‘outperform’ rating and a target price of Rs 3,830 per share. The target implies around 15 percent upside from MCX's Tuesday close of Rs 3,342. Bernstein sees commodities as an inflection opportunity, with equity derivatives offering a long runway for cross-pollination. MCX shares have surged 52.1 percent so far in 2026, giving the exchange a market capitalisation of more than Rs 85,200 crore.